Protective Role of L-3- n -Butylphthalide in Cognitive Function and Dysthymic Disorders in Mouse With Chronic Epilepsy

Epilepsy is a common neurological disease with recurrent seizures and neurobehavioral comorbidities, including cognitive impairment and psychiatric disorders. Recent studies suggest that L-3- -butylphthalide (NBP), an extract from the seeds of Linn. (Chinese celery), ameliorates cognitive dysfunctio...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in pharmacology Vol. 9; p. 734
Main Authors Ye, Xiaowen, Rong, Zhouyi, Li, Yanfang, Wang, Xintian, Cheng, Baoying, Cheng, Yiyun, Luo, Haijuan, Ti, Yue, Huang, Xiaohua, Liu, Zhaoji, Zhang, Yun-Wu, Zheng, Weihong, Zheng, Honghua
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 11.07.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Epilepsy is a common neurological disease with recurrent seizures and neurobehavioral comorbidities, including cognitive impairment and psychiatric disorders. Recent studies suggest that L-3- -butylphthalide (NBP), an extract from the seeds of Linn. (Chinese celery), ameliorates cognitive dysfunction in ischemia and/or Alzheimer's disease animal models. However, little is known about the role of NBP in epilepsy and the associated comorbidities. Here, using a pilocarpine-induced chronic epileptic mouse model, we found that NBP supplement not only alleviated seizure severity and abnormal electroencephalogram, but also rescued cognitive and emotional impairments in these epileptic mice. The possible underlying mechanisms may be associated with the protective role of NBP in reducing neuronal loss and in restoring the expression of neural synaptic proteins such as postsynaptic density protein 95 (PSD95) and glutamic acid decarboxylase 65/67 (GAD65/67). In addition, NBP treatment increased the transcription of neuroprotective factors, brain-derived neurotrophic factor and Klotho. These findings suggest that NBP treatment may be a potential strategy for ameliorating epileptogenesis and the comorbidities of cognitive and psychological impairments.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Zhouguang Wang, Wenzhou Medical University, China; Wladyslaw Lason, Institute of Pharmacology PAS, Poland
These authors have contributed equally to this work.
This article was submitted to Neuropharmacology, a section of the journal Frontiers in Pharmacology
Edited by: Jafri Malin Abdullah, University of Science, Malaysia
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2018.00734